< Back to previous page
Patent
Immunoglobulin single domain antibodies for delivery of mucosal vaccines
The present invention relates to single-domain antibodies that specifically bind aminopeptidase N (APN), and more in particular to polypeptides, and nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the single-domain antibodies of the present invention are capable of targeting a moiety to a mucosal surface.
Patent Publication Number: WO2021144415
Year filing: 2021
Year approval: 2022
Year publication: 2021
Status: Requested
URI: link to Espacenet
Technology domains: undefined
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit Gent